Name | tert-butyl 3,6-diazabicyclo[3.2.0]heptane-6-carboxylate |
---|---|
Synonyms |
tert-butyl 3,6-diazabicyclo[3.2.0]heptane-6-carboxylate
6-Boc-3,6-Diazabicyclo[3.2.0]heptane 2-Methyl-2-propanyl 3,6-diazabicyclo[3.2.0]heptane-6-carboxylate 3,6-Diazabicyclo[3.2.0]heptane-6-carboxylicacid,1,1-dimethylethyl ester 3,6-Diazabicyclo[3.2.0]heptane-6-carboxylic acid, 1,1-dimethylethyl ester 3,6-DIAZA-BICYCLO[3.2.0]HEPTANE-6-CARBOXYLIC ACID TERT-BUTYL ESTER (S,S)-6-Boc-3,6-Diazabicyclo[3.2.0]heptane |
Density | 1.1±0.1 g/cm3 |
---|---|
Boiling Point | 276.4±13.0 °C at 760 mmHg |
Molecular Formula | C10H18N2O2 |
Molecular Weight | 198.262 |
Flash Point | 120.9±19.8 °C |
Exact Mass | 198.136826 |
PSA | 41.57000 |
LogP | 0.23 |
Vapour Pressure | 0.0±0.6 mmHg at 25°C |
Index of Refraction | 1.501 |
HS Code | 2933990090 |
---|
~64% 122848-57-1 |
Literature: JANSSEN PHARMACEUTICA NV; BRANSTETTER, Bryan, James; LETAVIC, Michael, A.; LY, Kiev, S.; RUDOLPH, Dale, A.; SAVALL, Brad, M.; SHAH, Chandravadan, R.; SHIREMAN, Brock, T. Patent: WO2011/50202 A1, 2011 ; Location in patent: Page/Page column 50 ; WO 2011/050202 A1 |
~% 122848-57-1 |
Literature: JANSSEN PHARMACEUTICA NV; BRANSTETTER, Bryan, James; LETAVIC, Michael, A.; LY, Kiev, S.; RUDOLPH, Dale, A.; SAVALL, Brad, M.; SHAH, Chandravadan, R.; SHIREMAN, Brock, T. Patent: WO2011/50202 A1, 2011 ; WO 2011/050202 A1 |
~% 122848-57-1 |
Literature: JANSSEN PHARMACEUTICA NV; BRANSTETTER, Bryan, James; LETAVIC, Michael, A.; LY, Kiev, S.; RUDOLPH, Dale, A.; SAVALL, Brad, M.; SHAH, Chandravadan, R.; SHIREMAN, Brock, T. Patent: WO2011/50202 A1, 2011 ; WO 2011/050202 A1 |
~% 122848-57-1 |
Literature: JANSSEN PHARMACEUTICA NV; BRANSTETTER, Bryan, James; LETAVIC, Michael, A.; LY, Kiev, S.; RUDOLPH, Dale, A.; SAVALL, Brad, M.; SHAH, Chandravadan, R.; SHIREMAN, Brock, T. Patent: WO2011/50202 A1, 2011 ; WO 2011/050202 A1 |
~% 122848-57-1 |
Literature: JANSSEN PHARMACEUTICA NV; BRANSTETTER, Bryan, James; LETAVIC, Michael, A.; LY, Kiev, S.; RUDOLPH, Dale, A.; SAVALL, Brad, M.; SHAH, Chandravadan, R.; SHIREMAN, Brock, T. Patent: WO2011/50202 A1, 2011 ; WO 2011/050202 A1 |
~% 122848-57-1 |
Literature: JANSSEN PHARMACEUTICA NV; BRANSTETTER, Bryan, James; LETAVIC, Michael, A.; LY, Kiev, S.; RUDOLPH, Dale, A.; SAVALL, Brad, M.; SHAH, Chandravadan, R.; SHIREMAN, Brock, T. Patent: WO2011/50202 A1, 2011 ; WO 2011/050202 A1 |
~% 122848-57-1 |
Literature: JANSSEN PHARMACEUTICA NV; BRANSTETTER, Bryan, James; LETAVIC, Michael, A.; LY, Kiev, S.; RUDOLPH, Dale, A.; SAVALL, Brad, M.; SHAH, Chandravadan, R.; SHIREMAN, Brock, T. Patent: WO2011/50202 A1, 2011 ; WO 2011/050202 A1 |
Precursor 5 | |
---|---|
DownStream 0 |
HS Code | 2933990090 |
---|---|
Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |